# BONE ANCHORED PORT for Hemodialysis Treatment

> **NCT02069860** · NA · TERMINATED · sponsor: **Cendres+Métaux** · enrollment: 6 (actual)

## Conditions studied

- End-Stage Renal Disease Requiring Haemodialysis
- Hemodialysis Access Failure (Disorder)

## Interventions

- **DEVICE:** Bone Anchored Port System (BAP)

## Key facts

- **NCT ID:** NCT02069860
- **Lead sponsor:** Cendres+Métaux
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-04
- **Primary completion:** 2019-12-23
- **Final completion:** 2022-07-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069860, "BONE ANCHORED PORT for Hemodialysis Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02069860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*